CHICAGO / Mar 13, 2024 / Business Wire / Today, GE HealthCare (Nasdaq: GEHC) a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, announced the establishment of its philanthropic entity, the GE HealthCare Foundation. The Foundation will operate as a charitable organization, incorporated separately from GE HealthCare, focused on advancing equitable access to precision healthcare.
The GE HealthCare Foundation supports nonprofit organizations aimed at making healthcare more accessible, personal, human, and flexible – and ultimately, strive to remove barriers that separate underserved communities from equitable healthcare. With an initial focus on improving maternal health outcomes globally, the Foundation addresses a critical need: Every two minutesi, a woman dies due to pregnancy or childbirth-related complications, compounded by a severe shortageii in primary care and midwifery professionals worldwide.
“The GE HealthCare Foundation was born out of GE HealthCare’s legacy of delivering access to care, and a desire to advance health equity by reducing the limits and barriers faced by those in underserved communities,” said Danielle Halstrom, President of the GE HealthCare Foundation. “When we looked at where we could focus the Foundation’s first programs, the lack of resources and care for moms and babies around the world clearly indicated where we should start. Beginning our Foundation’s work, we look forward to continuing to expand that impact across other issue areas as an extension of our company’s mission striving for equitable healthcare access.”
Through grants to nonprofit organizations with proven track records, the Foundation is dedicating its philanthropic efforts to bolster access to specialized maternal care. Simultaneously, it is investing in training a workforce to provide critical support and save lives throughout the stages of pregnancy and childbirth. The Foundation’s inaugural grantees are:
The Foundation is committed to supporting leading nonprofits to improve the health and safety of mothers and babies in underserved and vulnerable communities. The Foundation will expand this approach into additional focus areas in the coming years.
In addition to these programs, the Foundation will support humanitarian relief during times of natural disasters and crises, as well as a colleague matching gifts program for U.S. employees.
To learn more about the Foundation, please visit https://www.gehealthcare.com/foundation.
About GE HealthCare
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with 51,000 colleagues working to create a world where healthcare has no limits. Follow us on LinkedIn, X (formerly Twitter), and Insights for the latest news, or visit our website https://www.gehealthcare.com/ for more information.
[i] A woman dies every two minutes due to pregnancy or childbirth: UN agencies. World Health Organization. 23 February 2023.
https://www.who.int/news/item/23-02-2023-a-woman-dies-every-two-minutes-due-to-pregnancy-or-childbirth--un-agencies
[ii] Nursing and midwifery. Key Facts. World Health Organization. 18 March 2022.
https://www.who.int/news-room/fact-sheets/detail/nursing-and-midwifery
Last Trade: | US$77.09 |
Daily Change: | -2.16 -2.73 |
Daily Volume: | 3,055,620 |
Market Cap: | US$35.220B |
December 05, 2024 December 03, 2024 December 01, 2024 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB